Who should avoid nattokinase?

The most serious bleeding event linked to nattokinase in the published record happened to someone who was not taking any other blood thinner.

Memorial Sloan Kettering's integrative medicine database documents a fatal internal bleed in an elderly woman using over-the-counter nattokinase [6] for an irregular heartbeat, with no concurrent anticoagulant. That single case reframes the whole question.

"Who should avoid nattokinase?" is rarely a yes-or-no answer. It is four different answers, depending on which tier you fall into.

Table of Contents

1. Why "Avoid" Is Not a Yes-or-No Question
2. Tier 1 — Do Not Take: Bleeding Disorders and Hemorrhagic History
3. Tier 2 — Clearance First: Anticoagulant and Antiplatelet Users
4. Tier 3 — Pause and Resume: Surgery, Dental Work and Procedures
5. Tier 4 — No Data, So Don't: Pregnancy, Nursing and Children
6. The Screens Most Lists Miss: Soy, Blood Pressure and Vitamin K2
7. What to Check on a Label When You Are Screening Yourself
8. Frequently Asked Questions
9. Conclusion
10. Research References

1. Why "Avoid" Is Not a Yes-or-No Question

Most safety pages hand you a single list and leave you to work out what to do with it. That is the wrong shape for this question, because the same enzyme carries very different consequences depending on your circumstances. A person with hemophilia and a person with a dental cleaning in three weeks both appear on standard "avoid" lists, yet one should never take nattokinase and the other simply needs a calendar reminder.

The evidence base makes this distinction necessary. The Nattokinase Atherothrombotic Prevention Study [1], the largest and longest trial available, randomised 265 participants of median age 65.3 to 2,000 FU daily or placebo for a median of 3 years. It reported no safety signal — but it enrolled people without clinical cardiovascular disease. Trials of this design exclude precisely the populations who need screening.

So the trial record and the case record answer different questions. The 6 pooled RCTs covering 546 participants tell you what happens to a screened, healthy population. The case reports tell you what happens when screening fails. This guide sorts readers into four tiers, from absolute exclusion to time-limited pause. If you want the broader picture first, our complete guide to nattokinase covers what the enzyme is and what it does before you get to who it is wrong for.

• Tier 1 — Do not take. Physiology makes the risk unacceptable.
• Tier 2 — Physician clearance and monitoring required before starting.
• Tier 3 — Time-limited pause, typically 1–2 weeks, then resume.
• Tier 4 — Avoid because safety data does not exist, not because harm is proven.

2. Tier 1 — Do Not Take: Bleeding Disorders and Hemorrhagic History

Nattokinase's entire mechanism is fibrinolytic: it degrades fibrin, the protein scaffold that holds clots together. If your capacity to form and maintain clots is already compromised, adding a fibrinolytic enzyme compounds an existing deficit rather than correcting anything. Hemophilia, von Willebrand disease and thrombocytopenia sit in this tier without qualification.

A history of hemorrhagic stroke belongs here too, and the distinction from ischemic stroke matters enormously. Hemorrhagic stroke is bleeding into the brain; ischemic stroke is a clot obstructing it. The 2008 case published in Internal Medicine [3] illustrates the danger precisely — a patient with cerebral microbleeds took nattokinase 400 mg daily for 7 consecutive days alongside aspirin and developed an acute cerebellar hemorrhage, with multiple additional microbleeds visible on MRI.

Active peptic ulcer disease and any current unhealed bleeding site follow the same logic. Memorial Sloan Kettering also documents a case requiring repeat valve replacement [6] after a patient self-substituted nattokinase for warfarin over a long period — a reminder that the enzyme is not an equivalent substitute for prescribed anticoagulation, and that treating it as one has caused documented harm.

3. Tier 2 — Clearance First: Anticoagulant and Antiplatelet Users

This is the largest group and the one most often mishandled. Warfarin, apixaban, rivaroxaban, heparin, aspirin and clopidogrel all reduce clotting capacity through mechanisms that overlap with nattokinase's fibrinolytic action. The concern is additive effect, not a chemical incompatibility — which is why the answer here is supervision rather than prohibition. Our detailed review of nattokinase as a natural blood thinner covers the interaction picture drug by drug.

Warfarin carries the highest documented concern because its therapeutic window is narrow and measurable. Adding a fibrinolytic agent can push INR above target, and the appropriate response is closer monitoring arranged in advance rather than a decision made privately. The 2008 cerebellar hemorrhage case involved aspirin alone at 400 mg daily of nattokinase — roughly four times the 100 mg found in a standard capsule.

Two practical points separate Tier 2 from Tier 1. First, disclosure has to be specific: name the product, the FU potency, and the daily dose, because "a natural blood thinner" tells a prescriber nothing actionable. Second, the MSKCC record of a fatal bleed with no concurrent anticoagulant [6] means clearance is a starting point, not a guarantee — the warning signs below still apply.

• Unexplained or disproportionate bruising
• Bleeding from minor cuts that takes noticeably longer to stop
• Blood in urine or stool, or unexplained nosebleeds
• Headache with any neurological symptom — treat as urgent

4. Tier 3 — Pause and Resume: Surgery, Dental Work and Procedures

Tier 3 is the tier most people misfile as permanent exclusion. Scheduled surgery does not mean you can never take nattokinase — it means you stop on a defined timeline and restart when your surgeon clears you. The American Society of Anesthesiologists and the American Association of Nurse Anesthetists recommend discontinuing herbal medications 1–2 weeks before elective procedures [5], and consumer-facing pharmacology references specify at least 2 weeks for nattokinase.

The disclosure gap is the real risk here, not the enzyme. The same review reports that 50–70% of surgical patients never tell their clinicians they are taking herbal products, and most do not stop them preoperatively. The Society for Perioperative Assessment and Quality Improvement consensus statement [4], which reviewed 83 dietary supplements, works from the principle that where a supplement offers no demonstrated perioperative benefit, there is little downside to pausing it.

Minor procedures count. Dental extractions, colonoscopies, biopsies and skin excisions all carry bleeding risk, and a short pause costs you nothing measurable — nattokinase's cardiovascular effects in the trial literature accumulate over sustained daily use, so this is not a supplement where brief interruption forfeits accumulated benefit.

5. Tier 4 — No Data, So Don't: Pregnancy, Nursing and Children

Tier 4 is different in kind from the first three. Nobody has demonstrated that nattokinase harms a pregnancy. The problem is that no reliable safety information exists for pregnant or breastfeeding women [9], and standard practice is to avoid it rather than generate the evidence one person at a time.

The physiological reasoning strengthens the caution. Pregnancy shifts coagulation balance toward clot formation as a protective adaptation against hemorrhage at delivery. Introducing a compound that acts on fibrinolytic pathways into a system that has deliberately rebalanced itself is not a small intervention, and the 265-participant NAPS cohort — median age 65.3 — offers no read-across to this population.

Children fall in the same tier for the same reason. Across the 6 pooled RCTs and 546 participants in the 2023 meta-analysis, no paediatric data was included. If you were taking nattokinase and discover you are pregnant, the practical step is to stop and speak with your OB-GYN rather than to search for reassurance.

6. The Screens Most Lists Miss: Soy, Blood Pressure and Vitamin K2

Soy. Nattokinase is produced by fermenting soybeans with Bacillus subtilis, and fermentation reduces allergenic protein without eliminating it. Soy is one of the "big eight" allergens responsible for roughly 90% of food-allergic reactions [8], with oral food challenge–proven prevalence of about 0.27% in the general population. There is also a mechanism specific to natto: cases of late-onset anaphylaxis attributed to poly-γ-glutamic acid formed during fermentation [7], which is not the same pathway as conventional soy protein allergy. If you react to natto specifically, a soy-protein test may not explain it.

Blood pressure that is already low. The 2023 meta-analysis found nattokinase reduced systolic pressure by 3.45 mmHg and diastolic by 2.32 mmHg against placebo [2]. Those are modest figures for someone with hypertension and an unwelcome addition for someone who already runs low or takes antihypertensive medication, where the effects stack. We cover the full picture in our review of nattokinase and blood pressure.

The vitamin K2 question. Whole natto contains substantial vitamin K2, which supports clotting factor synthesis and partially offsets the enzyme's blood-thinning action. Purified supplements typically remove K2 — which is useful for anyone already supplementing it separately, but removes a natural counterweight that eating natto provides. This is a reason the screening tiers matter more for capsules than for the traditional food, and it is a detail most contraindication lists omit entirely.

7. What to Check on a Label When You Are Screening Yourself

Once you know your tier, the label becomes a screening instrument rather than a marketing document. Three things carry real weight: the stated FU potency, whether the batch has been independently tested, and whether vitamin K2 has been removed. Products that list milligrams alone tell you the mass of extract but not the enzymatic activity, which is the figure clinical trials actually used. If you are unsure what potency means in practice, our nattokinase dosage guide explains how FU values map to the doses used in research.

BioAbsorb's Nattokinase Enzyme is standardised to 100 mg of natto extract delivering 2,000 FU per capsule — the potency used in the NAPS trial and the most commonly studied daily dose — with each batch third-party tested for nattokinase activity, heavy metals, gluten and microbial contaminants. It is formulated without vitamin K2, which is deliberate: it lets people already taking K2 separately manage the two independently, and it is exactly the formulation characteristic discussed in the previous section, so it should factor into your conversation with a prescriber rather than be assumed harmless.

Two honest caveats belong here. First, this product is natto-derived, so the soy screen in Tier 1 applies to it as it does to every soy-fermented nattokinase on the market — the allergen-free profile covers gluten, nuts, eggs, dairy, fish, shellfish and all animal products, not soy. Second, no label removes anyone from Tier 1 or Tier 2. It is manufactured in a GMP-certified Canadian facility using DRcaps delayed-release capsules that protect the enzyme from stomach acid without the phthalates found in conventional enteric coatings, and the 180-capsule bottle works out to roughly $0.28 per day. Quality manufacturing changes what you are taking. It does not change whether you should be taking it.

Frequently Asked Questions

I take a daily low-dose aspirin. Does that put me in Tier 1 or Tier 2?

Tier 2 — clearance and monitoring, not automatic exclusion. The distinction matters because the documented cerebellar hemorrhage case involved aspirin plus 400 mg of nattokinase daily [3] in someone who also had pre-existing cerebral microbleeds. Two risk factors compounded, at four times the dose in a standard capsule. Discuss it with your prescriber before starting.

How long before dental surgery should I stop?

Follow the same window as any surgery: 1–2 weeks, per anesthesiology guidance [5], and tell the dentist you have been taking it even if you stopped on schedule. Extractions and implants carry genuine bleeding risk, and a cleaning generally does not — when in doubt, ask the practice rather than deciding for yourself.

Can I take nattokinase instead of my prescribed blood thinner?

No, and this is the substitution with the clearest documented harm. Memorial Sloan Kettering records a patient who required repeat valve replacement [6] after self-substituting nattokinase for warfarin over an extended period. Prescribed anticoagulants are dosed and monitored against measurable targets; nattokinase is not.

I have a soy allergy but I can eat soy sauce fine. Is nattokinase safe for me?

Not safely assumable. Fermentation lowers allergen content — which is why heavily fermented condiments are often better tolerated — but the threshold dose for an allergic reaction is around 1 mg of soy protein [7], and natto has additionally been linked to late-onset anaphylaxis through poly-γ-glutamic acid. Tolerating soy sauce does not predict tolerating a natto-derived supplement.

Nothing on these lists applies to me. Does that mean it will work?

Screening clear is not the same as benefiting. The 3-year NAPS trial in 265 healthy adults found no effect on atherosclerosis progression [1], while the 546-participant meta-analysis found modest blood pressure reductions. Passing the safety screen tells you it is reasonable to try — not that it will do something for you.

What if I have already been taking it and I am in Tier 1?

Stop and contact a healthcare provider rather than tapering on your own, and mention the specific FU dose and how long you have been taking it. If you have any bleeding sign — unusual bruising, blood in urine or stool, or headache with neurological symptoms — treat it as urgent rather than as something to monitor at home.

Conclusion

The honest answer to "who should avoid nattokinase" is that a small group should never take it, a larger group needs a prescriber involved first, and most people who appear on standard warning lists simply need a 2-week pause around a procedure. If you have screened yourself into the clear and want a product standardised to the 2,000 FU potency used in clinical research, review the BioAbsorb Nattokinase Enzyme specifications — and take the tier list to your next appointment rather than acting on it alone.

Research References

1. Nattokinase atherothrombotic prevention study: A randomized controlled trial. Clinical Hemorheology and Microcirculation, Vol. 78 (2021). Randomised 265 participants of median age 65.3 to 2,000 FU nattokinase or placebo for a median of 3 years and found no significant difference in carotid intima-media thickness or arterial stiffness progression — the trial establishing that the healthy-population evidence base does not extend to screened-out groups.
2. Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Reviews in Cardiovascular Medicine, Vol. 24 (2023). Pooled 6 RCTs covering 546 participants, rating overall methodological quality high; found systolic blood pressure reduced by 3.45 mmHg and diastolic by 2.32 mmHg versus placebo, with no notable adverse events across included studies.
3. Cerebellar Hemorrhage Provoked by Combined Use of Nattokinase and Aspirin in a Patient with Cerebral Microbleeds. Internal Medicine, Vol. 47 (2008). Case report of acute cerebellar hemorrhage following nattokinase 400 mg daily for 7 consecutive days in a patient taking aspirin for secondary stroke prevention, supporting the article's Tier 1 and Tier 2 distinction.
4. Preoperative Management of Surgical Patients Using Dietary Supplements: Society for Perioperative Assessment and Quality Improvement Consensus Statement. Mayo Clinic Proceedings, Vol. 96 (2021). Expert consensus covering perioperative management of 83 dietary supplements, establishing the principle underlying the Tier 3 pause recommendation.
5. Use of herbal medication in the perioperative period: Potential adverse drug interactions. Journal of Clinical Anesthesia, Vol. 95 (2024). Peer-reviewed review reporting that 50–70% of surgical patients fail to disclose herbal medication use, and that the American Society of Anesthesiologists and American Association of Nurse Anesthetists recommend discontinuation 1–2 weeks before elective surgery.
6. Nattokinase — About Herbs Database. Memorial Sloan Kettering Cancer Center. Clinical reference documenting reported adverse events including severe allergic reactions in natto-sensitive patients, fatal internal bleeding in a patient not taking other anticoagulants, and valve thrombosis following self-substitution of nattokinase for warfarin.
7. Are fermented soyfoods hypoallergenic? Soy Nutrition Institute Global. Review concluding that fermentation reduces but does not eliminate soy allergen content, noting an eliciting threshold of approximately 1 mg of soy protein and documented cases of natto-induced late-onset anaphylaxis attributed to poly-γ-glutamic acid.
8. Soybean (f14) — Allergen Encyclopedia. Thermo Fisher Scientific. Clinical allergen reference identifying soy among the "big eight" allergens responsible for approximately 90% of food-allergic reactions and reporting oral food challenge-confirmed prevalence of 0.27% in the general population.
9. Nattokinase — Uses, Side Effects, Precautions, Interactions and Dosing. WebMD (drawing on Natural Medicines monograph data). Consumer clinical reference stating that reliable safety information for pregnancy and breastfeeding does not exist, that nattokinase may worsen bleeding disorders, and that discontinuation at least 2 weeks before scheduled surgery is advised.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.